Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
AstraZeneca
AZN
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$526M |
| 4 |
Microsoft
MSFT
|
+$521M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$386M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$494M |
| 2 |
SNDK
Sandisk
SNDK
|
+$482M |
| 3 |
Honeywell
HON
|
+$365M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$362M |
| 5 |
EA
Electronic Arts
EA
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.17% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Healthcare | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
XPeng
XPEV
$10.2B
| $160K | ﹤0.01% |
12,047
-152
| -1% | -$2.41K |
|
|
RDIB
3102
Reading International Class B
RDIB
$422M
| $154K | ﹤0.01% |
17,849
-116
| -0.6% | -$1.1K |
|
|
WHWK
3103
Whitehawk Therapeutics
WHWK
$232M
| $153K | ﹤0.01% |
33,420
+3,330
| +11% | +$13.9K |
|
3104
Sypris Solutions
SYPR
$42.1M
| $151K | ﹤0.01% |
62,103
+5,810
| +10% | +$18K |
|
3105
Korro Bio
KRRO
$204M
| $150K | ﹤0.01% |
+11,406
| New | +$142K |
|
3106
Sono-Tek
SOTK
$69.6M
| $147K | ﹤0.01% |
24,062
+2,100
| +10% | +$10.2K |
|
3107
AirSculpt Technologies
AIRS
$172M
| $146K | ﹤0.01% |
+32,339
| New | +$131K |
|
|
ACCS
3108
ACCESS Newswire
ACCS
$18.4M
| $143K | ﹤0.01% |
22,012
-2,344
| -10% | -$16.9K |
|
|
WBTN
3109
WEBTOON Entertainment Inc
WBTN
$1.52B
| $142K | ﹤0.01% |
12,420
| – | – |
|
|
LENZ
3110
LENZ Therapeutics
LENZ
$140M
| $142K | ﹤0.01% |
24,892
-16,982
| -41% | -$137K |
|
3111
RAVE Restaurant Group
RAVE
$41.8M
| $141K | ﹤0.01% |
42,988
+3,893
| +10% | +$11K |
|
3112
Expensify
EXFY
$208M
| $140K | ﹤0.01% |
78,173
| – | – |
|
3113
Spruce Power Holding Corp
SPRU
$29.5M
| $138K | ﹤0.01% |
53,607
-10,783
| -17% | -$35.2K |
|
|
LONA
3114
LeonaBio Inc
LONA
$70.4M
| $135K | ﹤0.01% |
+14,728
| New | +$137K |
|
3115
TechPrecision Corp
TPCS
$54.7M
| $135K | ﹤0.01% |
25,710
+7,004
| +37% | +$26.9K |
|
|
SRG
3116
Seritage Growth Properties
SRG
$111M
| $132K | ﹤0.01% |
50,385
+6,265
| +14% | +$16.5K |
|
3117
Zevia
ZVIA
$93.1M
| $131K | ﹤0.01% |
80,491
-133,828
| -62% | -$182K |
|
|
NTSK
3118
Netskope Inc
NTSK
$6.95B
| $130K | ﹤0.01% |
11,840
-1,214
| -9% | -$12.4K |
|
3119
Pulmonx
LUNG
$84.6M
| $127K | ﹤0.01% |
97,791
-44,129
| -31% | -$60.8K |
|
3120
Arts-Way Manufacturing Co
ARTW
$15.8M
| $124K | ﹤0.01% |
47,306
+2,627
| +6% | +$6.84K |
|
3121
Aligos Therapeutics
ALGS
$31.5M
| $121K | ﹤0.01% |
+21,044
| New | +$130K |
|
3122
Instil Bio
TIL
$50.5M
| $121K | ﹤0.01% |
15,761
-4,214
| -21% | -$34K |
|
3123
Bakkt Inc
BKKT
$373M
| $121K | ﹤0.01% |
+15,495
| New | +$139K |
|
3124
OPAL Fuels
OPAL
$56M
| $119K | ﹤0.01% |
54,038
+20,401
| +61% | +$44.8K |
|
3125
PetMed Express
PETS
$36.2M
| $116K | ﹤0.01% |
60,353
-147,416
| -71% | -$313K |
|
Similar funds
Dimensional Fund Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Dimensional Fund Advisors held 3,315 positions worth $552B, up 15% from $481B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q2 2026 filing shows 100 new, 1,949 increased, 1,085 reduced and 94 closed positions. Its largest new stake was AstraZeneca: 2,904,886 shares worth $551M. The largest sale was Advanced Micro Devices, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2026 buy was AstraZeneca: 2,904,886 shares worth $551M.
- Dimensional Fund Advisors added most to Amazon in Q2 2026, an estimated $747M increase.
- Dimensional Fund Advisors's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $494M.
- Dimensional Fund Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $362M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $552B portfolio in Q2 2026.
- Dimensional Fund Advisors opened 100 new positions and closed 94 in Q2 2026.
- Dimensional Fund Advisors's portfolio value rose 15% quarter-over-quarter to $552B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.